Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort study [0.03%]
advanced Parkinson病早期使用皮下注射左旋多巴/卡比多巴缓释剂的6个月结局：回顾性队列研究
C Desjardins,H de Saint Vaulry,C Rosset et al.
C Desjardins et al.
The optimal setting for initiating subcutaneous foslevodopa/foscarbidopa (CSFLI) in advanced Parkinson's disease remains debated. This study aimed to compare six-month clinical outcomes according to initiation setting. We conducted a retros...
Establishing age-stratified reference values for blood Neurofilament Light chain (NfL) using the Lumipulse® platform [0.03%]
使用Lumipulse平台建立血浆神经丝轻链年龄分层参考值
A Hanin,S Bahroun,V Chiodega et al.
A Hanin et al.
Objectives: Neurofilament light chain (NfL) is a sensitive biomarker of neuroaxonal injury detectable in blood and cerebrospinal fluid. Its concentrations are strongly influenced by age, yet no age-specific reference valu...
P Corcia,E Bernard,E de la Cruz et al.
P Corcia et al.
Primary lateral sclerosis (PLS) is a rare neurodegenerative motor neuron disease characterized by progressive and selective involvement of the central motor neuron within the bulbar and spinal regions. It is estimated to account for 1-5% of...
Practice Guideline
Revue neurologique. 2026 May 21:S0035-3787(26)00525-4. DOI:10.1016/j.neurol.2026.04.006 2026
Real-world utilization of acute treatments for cluster headache: Insights from the French National Open Health Data [0.03%]
法国国家公开健康数据的丛集性头痛急性治疗应用情况及其启示
V Arcani,A Bruyat,G Hache et al.
V Arcani et al.
Background: The utilization of open health databases offers a unique opportunity to analyze the dispensing of healthcare products within real-world populations. A recent study by Van Obberghen et al. (2025) was the first ...
Level of consciousness, wakefulness and responsiveness in epileptic seizures [0.03%]
癫痫发作时的意识水平、觉醒程度和反应能力
S Beniczky,P Ryvlin,P Kahane et al.
S Beniczky et al.
C Louapre
C Louapre
7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs [0.03%]
7特斯拉磁共振脊髓成像在多发性硬化领域的应用进展、新视野和未满足需求
V Callot,A Destruel,S Demortière et al.
V Callot et al.
Magnetic resonance imaging (MRI) is central to the diagnosis and monitoring of multiple sclerosis (MS). While conventional MRI (1.5 or 3T) is sufficient in clinical practice for detecting and monitoring lesions, it fails to provide a compre...
The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential [0.03%]
EB病毒在多发性硬化中的作用：从发病机制到治疗潜力
G Bellucci,R Mechelli,R Bigi et al.
G Bellucci et al.
A growing body of evidence positions Epstein-Barr virus (EBV) as a central agent in the etiopathogenesis of multiple sclerosis (MS). Compelling epidemiological studies now demonstrate that EBV infection precedes MS onset and is a necessary ...
New immunotherapies for multiple sclerosis (MS): A comprehensive review [0.03%]
新的多发性硬化症(MS)免疫疗法：全面回顾
X Ayrignac
X Ayrignac
Multiple sclerosis (MS) is the leading cause of non-traumatic disability in young adults, characterized by autoimmune demyelination and neurodegeneration. While high-efficacy therapies have transformed relapsing MS management, disability pr...
Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study [0.03%]
法国ALS患者的治疗路径、医疗资源利用及直接医疗成本：全国性理赔数据库研究
C Desnuelle,P Couratier,P Corcia et al.
C Desnuelle et al.
Objective: Amyotrophic lateral sclerosis (ALS) is a severe, progressive disease, associated with high clinical burden. The aim of this study was to estimate ALS-related healthcare resource utilization (HCRU), associated d...